Pfizer Inc. (LON:0Q1N)
London
· Delayed Price · Currency is GBP · Price in USD 24.95
-0.10 (-0.40%)
At close: Mar 31, 2025
Pfizer Ratios and Metrics
Market cap in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 28, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 107,672 | 120,091 | 127,623 | 238,715 | 244,775 | 149,861 | Upgrade
|
| Market Cap Growth | -5.90% | -5.90% | -46.54% | -2.48% | 63.33% | -8.46% | Upgrade
|
| Enterprise Value | 144,214 | 166,631 | 143,498 | 239,650 | 252,494 | 188,584 | Upgrade
|
| Last Close Price | 19.30 | 20.78 | 20.90 | 37.62 | 36.77 | 22.47 | Upgrade
|
| PE Ratio | 16.78 | 18.72 | 76.72 | 9.17 | 15.08 | 22.34 | Upgrade
|
| PS Ratio | 2.36 | 2.36 | 2.73 | 2.84 | 4.08 | 4.91 | Upgrade
|
| PB Ratio | 1.70 | 1.70 | 1.82 | 3.00 | 4.28 | 3.22 | Upgrade
|
| P/TBV Ratio | - | - | - | 314.00 | 116.42 | - | Upgrade
|
| P/FCF Ratio | 15.29 | 15.29 | 33.92 | 11.05 | 11.10 | 16.80 | Upgrade
|
| P/OCF Ratio | 11.80 | 11.80 | 18.68 | 9.83 | 10.17 | 14.21 | Upgrade
|
| EV/Sales Ratio | 2.93 | 3.28 | 3.07 | 2.85 | 4.21 | 6.18 | Upgrade
|
| EV/EBITDA Ratio | 7.58 | 8.95 | 14.54 | 6.44 | 10.66 | 17.81 | Upgrade
|
| EV/EBIT Ratio | 11.35 | 12.78 | 28.94 | 7.25 | 12.67 | 26.30 | Upgrade
|
| EV/FCF Ratio | 18.36 | 21.21 | 38.14 | 11.09 | 11.45 | 21.14 | Upgrade
|
| Debt / Equity Ratio | 0.76 | 0.76 | 0.84 | 0.41 | 0.53 | 0.65 | Upgrade
|
| Debt / EBITDA Ratio | 2.75 | 2.75 | 5.44 | 0.85 | 1.26 | 2.71 | Upgrade
|
| Debt / FCF Ratio | 6.86 | 6.86 | 15.72 | 1.51 | 1.39 | 3.39 | Upgrade
|
| Asset Turnover | 0.29 | 0.29 | 0.28 | 0.53 | 0.48 | 0.26 | Upgrade
|
| Inventory Turnover | 1.56 | 1.56 | 2.50 | 3.78 | 3.59 | 1.11 | Upgrade
|
| Quick Ratio | 0.82 | 0.82 | 0.59 | 0.88 | 1.10 | 0.90 | Upgrade
|
| Current Ratio | 1.17 | 1.17 | 0.91 | 1.22 | 1.40 | 1.35 | Upgrade
|
| Return on Equity (ROE) | 9.06% | 9.06% | 2.35% | 36.22% | 31.87% | 10.50% | Upgrade
|
| Return on Assets (ROA) | 4.64% | 4.64% | 1.86% | 13.15% | 10.05% | 3.80% | Upgrade
|
| Return on Capital (ROIC) | 6.37% | 6.37% | 2.63% | 19.60% | 15.08% | 5.52% | Upgrade
|
| Return on Capital Employed (ROCE) | 9.60% | 9.60% | 3.50% | 25.70% | 19.40% | 7.60% | Upgrade
|
| Earnings Yield | 5.96% | 5.34% | 1.30% | 10.91% | 6.63% | 4.48% | Upgrade
|
| FCF Yield | 7.30% | 6.54% | 2.95% | 9.05% | 9.01% | 5.95% | Upgrade
|
| Dividend Yield | 5.32% | 6.46% | 6.16% | 3.53% | 3.13% | 4.95% | Upgrade
|
| Payout Ratio | 118.44% | 118.44% | 436.39% | 28.63% | 39.72% | 92.15% | Upgrade
|
| Buyback Yield / Dilution | 0.16% | 0.16% | 0.42% | -0.44% | -1.35% | 0.76% | Upgrade
|
| Total Shareholder Return | 5.47% | 6.62% | 6.58% | 3.09% | 1.79% | 5.71% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.